Results 151 to 160 of about 2,313,793 (272)

Trackins (Trk-Targeting Drugs): A Novel Therapy for Different Diseases

open access: yesPharmaceuticals
Many routes may lead to the transition from a healthy to a diseased phenotype. However, there are not so many routes to travel in the opposite direction; that is, therapy for different diseases.
George N. Chaldakov   +8 more
doaj   +1 more source

Endogenous neurotrophins are required for the induction of GABAergic long-term potentiation in the neonatal rat hippocampus.

open access: yes, 2005
International audienceIn the developing rat hippocampus, GABAergic synapses undergo a Ca2+-dependent long-term potentiation (LTP(GABA-A)); this form of synaptic plasticity is induced in CA3 pyramidal neurons by delivering repetitive depolarizing pulses ...
Ben-Ari, Yehezkel   +2 more
core   +5 more sources

TrkA, but not TrkC, receptors are essential for survival of sympathetic neurons in vivo.

open access: green, 1996
Anne M. Fagan   +5 more
openalex   +2 more sources

BPI-28592 as a novel second generation inhibitor for NTRK fusion tumors

open access: yesnpj Precision Oncology
Aberrant activation of tropomyosin receptor kinases (TRKs) is a well-defined oncogenic driver for neurotrophic tropomyosin receptor kinase (NTRK)-fusion cancers, and acquired resistant mutations have emerged with clinical use of the first-generation TRK ...
Jin Sheng   +5 more
doaj   +1 more source

Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma

open access: yesDrug Design, Development and Therapy, 2018
Holly L Pacenta, Margaret E Macy Department of Pediatrics, University of Colorado Anschutz Medical Campus and Children’s Hospital Colorado, Aurora, CO, USA Abstract: RTK plays important roles in many cellular signaling processes involved in ...
Pacenta HL, Macy ME
doaj  

Home - About - Disclaimer - Privacy